These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17885556)

  • 21. Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder.
    Esler M; Alvarenga M; Lambert G; Kaye D; Hastings J; Jennings G; Morris M; Schwarz R; Richards J
    Ann N Y Acad Sci; 2004 Jun; 1018():505-14. PubMed ID: 15240408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses.
    Esler M
    Pharmacol Toxicol; 1993 Nov; 73(5):243-53. PubMed ID: 8115306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neural mechanisms in human obesity-related hypertension.
    Rumantir MS; Vaz M; Jennings GL; Collier G; Kaye DM; Seals DR; Wiesner GH; Brunner-La Rocca HP; Esler MD
    J Hypertens; 1999 Aug; 17(8):1125-33. PubMed ID: 10466468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
    Ninan PT; Hassman HA; Glass SJ; McManus FC
    J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased central nervous system monoamine neurotransmitter turnover and its association with sympathetic nervous activity in treated heart failure patients.
    Lambert GW; Kaye DM; Lefkovits J; Jennings GL; Turner AG; Cox HS; Esler MD
    Circulation; 1995 Oct; 92(7):1813-8. PubMed ID: 7545554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy.
    Barton DA; Esler MD; Dawood T; Lambert EA; Haikerwal D; Brenchley C; Socratous F; Hastings J; Guo L; Wiesner G; Kaye DM; Bayles R; Schlaich MP; Lambert GW
    Arch Gen Psychiatry; 2008 Jan; 65(1):38-46. PubMed ID: 18180427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased cardiac sympathetic nervous activity in patients with unstable coronary heart disease.
    McCance AJ; Thompson PA; Forfar JC
    Eur Heart J; 1993 Jun; 14(6):751-7. PubMed ID: 8325300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biochemical evidence of sympathetic denervation of the heart in pure autonomic failure.
    Meredith IT; Esler MD; Cox HS; Lambert GW; Jennings GL; Eisenhofer G
    Clin Auton Res; 1991 Sep; 1(3):187-94. PubMed ID: 1822251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog.
    Eisenhofer G; Smolich JJ; Cox HS; Esler MD
    Circulation; 1991 Sep; 84(3):1354-63. PubMed ID: 1884458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An open study of triiodothyronine augmentation of selective serotonin reuptake inhibitors in treatment-resistant major depressive disorder.
    Iosifescu DV; Nierenberg AA; Mischoulon D; Perlis RH; Papakostas GI; Ryan JL; Alpert JE; Fava M
    J Clin Psychiatry; 2005 Aug; 66(8):1038-42. PubMed ID: 16086620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
    Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
    CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The under-recognized role of dopamine in the treatment of major depressive disorder.
    Montgomery SA
    Int Clin Psychopharmacol; 2008 Mar; 23(2):63-9. PubMed ID: 18301120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cardiac production of dihydroxyphenylalanine (DOPA) during sympathetic stimulation in anaesthetized dogs.
    Eisenhofer G; Smolich JJ; Esler MD
    Neurochem Int; 1992 Jul; 21(1):37-44. PubMed ID: 1303141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.
    Leo R; Di Lorenzo G; Tesauro M; Razzini C; Forleo GB; Chiricolo G; Cola C; Zanasi M; Troisi A; Siracusano A; Lauro R; Romeo F
    J Clin Psychiatry; 2006 Nov; 67(11):1760-6. PubMed ID: 17196057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
    Papakostas GI; Nutt DJ; Hallett LA; Tucker VL; Krishen A; Fava M
    Biol Psychiatry; 2006 Dec; 60(12):1350-5. PubMed ID: 16934768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human muscle sympathetic activity and cardiac catecholamine spillover: no support for augmented sympathetic noradrenaline release by adrenaline co-transmission.
    Thompson JM; Wallin BG; Lambert GW; Jennings GL; Esler MD
    Clin Sci (Lond); 1998 Apr; 94(4):383-93. PubMed ID: 9640344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity.
    Lambert GW; Kaye DM; Thompson JM; Turner AG; Cox HS; Vaz M; Jennings GL; Wallin BG; Esler MD
    Acta Physiol Scand; 1998 Jun; 163(2):155-63. PubMed ID: 9648634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study.
    McIntyre RS; Prieto R; Schepman P; Yeh YC; Boucher M; Shelbaya A; Chambers R; Gao X; Pappadopulos E
    Curr Med Res Opin; 2019 Dec; 35(12):2169-2177. PubMed ID: 31370711
    [No Abstract]   [Full Text] [Related]  

  • 40. Sympathetic and cardiac baroreflex function in panic disorder.
    Lambert EA; Thompson J; Schlaich M; Laude D; Elghozi JL; Esler MD; Lambert GW
    J Hypertens; 2002 Dec; 20(12):2445-51. PubMed ID: 12473870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.